Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: Regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 1, 1996, Pages 22-31

  Schaefer, Franz ^a,d   Baumann, Gerhard ^c   Haffner, Dieter ^a   Faunt, Lindsay M ^b   Johnson, Michael L ^b   Mercado, Moises ^c   Ritz, Eberhard ^a   Mehls, Otto ^a   Veldhuis, Johannes D ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE BINDING PROTEIN; HUMAN GROWTH HORMONE; OCTREOTIDE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BODY MASS; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE RESPONSE; DRUG ELIMINATION; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; IMMUNORADIOMETRIC ASSAY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; METABOLIC CLEARANCE RATE; MODEL; OBESITY; PRIORITY JOURNAL; STEADY STATE;

ADOLESCENT; ADULT; AGE FACTORS; CARRIER PROTEINS; FEMALE; GROWTH HORMONE; HUMANS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; OBESITY; PROTEIN BINDING; RECEPTORS, SOMATOTROPIN; RECOMBINANT PROTEINS;

EID: 0030060620     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.1.22     Document Type: Article

References (48)

1. Parker ML, Utiger RD, Daughaday WH. 1962 Studies on human growth hormone. II. The physiological disposition and metabolic clearance rate of human growth hormone in man. J Clin Invest. 41:262-270.
2. Cameron DP, Burger HG, Catt KJ, Doig A. 1969 Metabolic clearance rate of radioiodinated human growth hormone in man. J Clin Invest. 48:1600-1608.
3. Taylor AL, Finster JL, Mintz DH. 1969 Metabolic clearance and production rates of human growth hormone. J Clin Invest. 48:2349-2358.
4. McGillivray MH, Frohman LA, Doe J. 1970 Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth. J Clin Endocrinol Metab. 30:632-638.
5. Kowarski A, Thompson RC, Migeon CJ, Blizzard RM. 1971 Determination of integrated plasma concentrations and true secretion rates of human growth hormone. J Clin Endocrinol Metab. 32:356-360.
6. Owens D, Srivastave MC, Tompkins CV, Nabarro JDN, Soenksen PH. 1973 Studies on the metabolic clearance rate, apparent distribution space and plasma half-disappearance time of unlabelled human growth hormone in normal subjects and in patients with liver disease, renal disease, thyroid disease and diabetes mellitus. Eur J Clin Invest. 3:284-294.
7. Rosenbaum M, Gertner JM. 1989 Metabolic clearance rates of synthetic human growth hormone in children, adult women, and adult men. J Clin Endocrinol Metab. 69:821-824.
8. Boucher BJ. 1966 Disappearance of iodine-131-labelled human growth hormone from the plasma of diabetic, non-diabetic and acromegalic subjects. Nature. 210:1288-1295.
9. Hendricks CM, Eastman RC, Takeda S, Asakawa K, Gordon P. 1985 Plasma clearance of intravenously administered pituitary human growth hormone: gel filtration studies of heterogeneous components. J Clin Endocrinol Metab. 60: 864-867.
10. Cameron DP, Burger HG, Catt KJ, Gordon E, Watts JM. 1972 Metabolic clearance of human growth hormone in patients with hepatic and renal failure, and in the isolated perfused pig liver. Metabolism. 21:895-904.
11. 3) in systemic illnesses. J Clin Endocrinol Metab. 41:1043-1049.
12. Haffner D, Schaefer F, Girard J, Ritz E, Mehls O. 1994 Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. J Clin Invest. 93:1163-1171.
13. Refetoff S, Sonksen PH. 1970 Disappearance rate of endogenous and exogenous human growth hormone in man. J Clin Endocrinol Metab. 30:386-391.
14. Dubdey AK, Ahanukoglu A, Hansen BC, Kowarski AA. 1988 Metabolic clearance rates of synthetic human growth hormone in lean and obese rhesus monkeys. J Clin Endocrinol Metab. 67:1064-1067.
15. Veldhuis JD, Iranmanesh A, Ho KKY, Waters MJ, Johnson ML, Lizarralde G. 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab. 72:51-59.
16. Iranmanesh A, Lizarralde G, Veldhuis JD. 1991 Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 73:1081-1088.
17. Baumann G, Stolar MW, Amburn K, Barsano CP, DeVries BC. 1986 A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab. 62:134-141.
18. Herington AC, Ymer S, Stevenson J. 1986 Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest. 77:1817-1823.
19. Baumann G, Amburn KD, Buchanan TA. 1987 The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone. J Clin Endocrinol Metab. 64:657-660.
20. Veldhuis JD, Johnson ML, Faunt LM, Mercado M, Baumann G. 1993 Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications. J Clin Invest. 91:629-641.
21. Baumann G, Shaw MA, Amburn K. 1989 Regulation of plasma growth hormone-binding proteins in health and disease. Metabolism. 38:683-689.
22. Postel-Vinay MC, Tar A, Crosnier H, et al. 1991 Plasma growth-hormone binding is low in uremic children. Pediatr Nephrol. 5:545-547.
23. Girard J, Erb T, Pampalone A, Eberle AN, Baumann JB. 1987 Growth hormone in urine: development of an ultrasensitive assay applicable to plasma and urine. Horm Res. 28:71-80.
24. Baumann G, Amburn K, Shaw MA. 1988 The circulating growth hormone (GH)-binding protein complex: a major constituent of plasma GH in man. Endocrinology. 122:976-984.
25. Jan T, Shaw MA, Winer LM, Baumann G. 1991 Effects of growth hormone-binding protein on serum growth hormone measurements. J Clin Endocrinol Metab. 72:387-391.
26. Snow KJ, Shaw MA, Winer LM, Baumann G. 1990 Diurnal pattern of plasma growth hormone-binding protein in man. J Clin Endocrinol Metab. 70:417-420.
27. Carlsson LMS, Rosber S, Vitangcol RV, Wong WLT. 1993 Analysis of 24-hour plasma profiles of growth hormone (GH)-binding protein, GH/GH-binding protein complex, and GH in healthy children. J Clin Endocrinol Metab. 77: 356-361.
28. Barsano CP, Baumann G. 1989 Editorial: simple algebraic and graphic methods for the apportionment of hormone (and receptor) into bound and free fractions in binding equilibria; or how to calculate bound and free hormone? Endocrinology. 124:1101-1106.
29. SAS Institute. 1988 SAS/STAT user's guide, release 6.03 ed. Cary: SAS Institute.
30. Jørgensen JOL, Flyvbjerg A, Christiansen JS, 1989 The metabolic clearance rate, serum half-time and apparent distribution space of authentic biosynthetic human growth hormone in human growth hormone-deficient patients. Acta Endocrinol (Copenh). 120:8-13.
31. Faria ACS, Veldhuis JD, Thorner MO, Vance ML. 1989 Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. J Clin Endocrinol Metab. 68:535-541.
32. Bick T, Youdim MB, Hochberg Z. 1989 Adaptation of liver membrane somatogenic and lactogenic growth hormone (GH) binding to the spontaneous pulsation of GH secretion in the male rat. Endocrinology, 125:1711-1717.
33. Imaki T, Shibasaki T, Shizume K, et al. 1985 The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endorinol Metab. 60:290-293.
34. Yamashita S, Melmed S. 1986 Effects of insulin on rat anterior pituitary cells; inhibition of growth hormone secretion and mRNA levels. Diabetes. 35:440-447.
35. Golzy A, Swislocki AL, Chen YD, Jaspan JB, Reaven GM. 1986 Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab. 63:481-484.
36. Rosskamp R, Becker M, Soetadji S. 1987 Circulating somatomedin-C levels and the effect of growth hormone-releasing factor on plasma levels of growth hormone and somatostatin-like immunoreactivity in obese children. Eur J Pediatr. 146:48-50.
37. Cameron CM, Kostyo JL, Adamafio NA, Dunbar JC. 1987 Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse. Endocrinology. 120:1568-1575.
38. Casanueva FF, Villanueva L, Dieguez C, et al. 1987 Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J Clin Endocrinol Metab. 65:634-642.
39. Barnard R, Waters MJ. 1986 Serum and liver cytosolic growth hormone-binding proteins are antigenically identical with liver membrane "receptor" types 1 and 2. Biochem J. 237:885-892.
40. Leung DW, Spencer SA, Cachianes G, et al. 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature. 330: 537-543.
41. Baumann G, Shaw MA. 1988 Immunochemical similarity of the human plasma growth hormone-binding protein and the rabbit liver growth hormone receptor. Biochem Biophys Res Commun. 152:573-578.
42. Mulumba N, Massa G, Ketelslegers JM, Maes M. 1991 Ontogeny and nutritional regulation of the serum growth hormone-binding protein in the rat. Acta Endocrinol (Copenh). 125:409-415.
43. Daughaday WH, Trivedi B. 1987 Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc Natl Acad Sci USA. 84:4636-4640.
44. Baumann G, Shaw MA, Winter RJ. 1987 Absence of the plasma growth hormone-binding protein in Laron-type dwarfism. J Clin Endocrinol Metab. 65:814-816.
45. Baumann G, Vance ML, Shaw MA, Thorner MO. 1990 Plasma transport of human growth hormone in vivo. J Clin Endocrinol Metab. 71:470-473.
46. Maheshwari HG, Rifkin J, Butler T, Norman M. 1992 Growth hormone binding protein in patients with renal failure. Acta Endocrinol (Copenh). 127:485-488.
47. Daughaday WH, Trivedi B, Andrews BA. 1987 The ontogeny of serum GH binding protein in man: a possible indicator of hepatic GH receptor development. J Clin Endocrinol Metab. 65:1072-1074.
48. Silbergeld A, Lazar L, Erster B, Keret R, Tepper R, Laron Z. 1989 Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlations with age, height and weight. Clin Endocrinol (Oxf). 31:295-303.